• 1
    Basilico C,Moscatelli D. The FGF family of growth factors and oncogenes. Adv Cancer Res 1992; 59: 11565.
  • 2
    Bikfalvi A,Klein S,Pintucci G,Rifkin DB. Biological roles of fibroblast growth factor-2. Endocr Rev 1997; 18: 2645.
  • 3
    Inoue K,Slaton JW,Karashima T,Yoshikawa C,Shuin T,Sweeney P,Millikan R,Dinney CP. The prognostic value of angiogenesis factor expression for predicting recurrence and metastasis of bladder cancer after neoadjuvant chemotherapy and radical cystectomy. Clin Cancer Res 2000; 6: 486673.
  • 4
    Li Z,Shimada Y,Uchida S,Maeda M,Kuwabe A,Mori A,Itami A,Kano M,Watanabe G,Imamura M. TGF-alpha as well as VEGF, PD-ECGF and bFGF contribute to angiogenesis of esophageal squamous cell carcinoma. Int J Oncol 2000; 17: 45360.
  • 5
    Yamanaka Y,Friess H,Buchler M,Beger HC,Huchida F,Onda M,Kobrin MS,Korc M. Overexpression of acidic and basic fibroblast growth factors in human pancreatic cancer correlates with advanced tumor stage. Cancer Res 1993; 53: 52895296.
  • 6
    Shou Y,Hirano T,Gong YKato Y,Yoshida K,Ohira T,Ikeda N,Konaca C,Ebihara Y,Zhao F,Kato H. Influence of angiogenetic factors and matrix metalloproteinases upon tumour progression in non-small-cell lung cancer. Br J Cancer 2001; 85: 170612.
  • 7
    Stefanik DF,Rizkalla LR,Soi A,Goldblatt SA,Rizkalla WM. Acidic and basic fibroblast growth factors are present in glioblastoma multiforme. Cancer Res 1991; 51: 57605.
  • 8
    Florkiewicz RZ,Sommer A. Human basic fibroblast growth factor gene encodes four polypeptides: three initiate translation from non-AUG codons. Proc Natl Acad Sci USA 1989; 86: 397881.
  • 9
    Prats H,Kaghad M,Prats AC,Klagsbrun M,Lélias JM,Liauzun P,Chalon P,Tauber JP,Amalric F,Smith JA,Caput D. High molecular mass forms of basic fibroblast growth factor are initiated by alternative CUG codons. Proc Natl Acad Sci USA 1989; 86: 183640.
  • 10
    Arnaud E,Touriol C,Boutonnet C,Gensac MC,Vagner S,Prats H,Prats AC. A new 34-kilodalton isoform of human fibroblast growth factor 2 is cap dependently synthesized by using a non-AUG start codon and behaves as a survival factor. Mol Cell Biol 1999; 19: 50514.
  • 11
    Renko M,Quarto N,Morimoto T,Rifkin DB. Nuclear and cytoplasmic localization of different basic fibroblast growth factor species. J Cell Physiol 1990; 144: 10814.
  • 12
    Bugler B,Amalric F,Prats H. Alternative initiation of translation determines cytoplasmic or nuclear localization of basic fibroblast growth factor. Mol Cell Biol 1991; 11: 5737.
  • 13
    Florkiewicz RZ,Baird A,Gonzalez AM. Multiple forms of bFGF: differential nuclear and cell surface localization. Growth Factors 1991; 4: 26575.
  • 14
    Misumi Y,Misumi Y,Miki K,Takatsuki A,Tamura G,Ikehara Y. Novel blockade by brefeldin A of intracellular transport of secretory proteins in cultured rat hepatocytes. J Biol Chem 1986; 261: 11398403.
  • 15
    Mignatti P,Morimoto T,Rifkin DB. Basic fibroblast growth factor, a protein devoid of secretory signal sequence, is released by cells via a pathway independent of the endoplasmic reticulum-Golgi complex. J Cell Physiol 1992; 151: 8193.
  • 16
    Florkiewicz RZ,Majack RA,Buechler RD,Florkiewicz E. Quantitative export of FGF-2 occurs through an alternative, energy-dependent, non-ER/Golgi pathway. J Cell Physiol 1995; 162: 38899.
  • 17
    Schäfer T,Zentgraf H,Zehe C,Brügger B,Bernhagen J,Nickel W. Unconventional secretion of fibroblast growth factor 2 is mediated by direct translocation across the plasma membrane of mammalian cells. J Biol Chem 2004; 279: 624451.
  • 18
    Florkiewicz RZ,Anchin J,Baird A. The inhibition of fibroblast growth factor-2 export by cardenolides implies a novel function for the catalytic subunit of Na+,K+-ATPase. J Biol Chem 1998; 273: 54451.
  • 19
    Dahl JP,Binda A,Canfield VA,Levenson R. Participation of Na,K-ATPase in FGF-2 secretion: rescue of ouabain-inhibitable FGF-2 secretion by ouabain-resistant Na,K-ATPase alpha subunits. Biochemistry 2000; 39: 1487783.
  • 20
    Smith JA,Madden T,Vijjeswarapu M,Newman RA. Inhibition of export of fibroblast growth factor-2 (FGF-2) from the prostate cancer cell lines PC3 and DU145 by Anvirzel and its cardiac glycoside component, oleandrin. Biochem Pharmacol 2001; 62: 46972.
  • 21
    Pagano JS,Blaser M,Buendia M-A,Damania B,Khalili K,Raab-Traub N,Roizman B. Infectious agents and cancer: criteria for a causal relation. Semin Cancer Biol 2004; 14: 45371.
  • 22
    Yoshizaki T,Sato H,Furukawa M,Pagano JS. The expression of matrix metalloproteinase 9 is enhanced by Epstein-Barr virus latent membrane protein 1. Proc Natl Acad Sci USA 1998; 95: 36216.
  • 23
    Murono S,Inoue H,Tanabe T,Joab I,Yoshizaki T,Furukawa M,Pagano JS. Induction of cyclooxygenase-2 by Epstein-Barr virus latent membrane protein 1 is involved in vascular endothelial growth factor production in nasopharyngeal carcinoma cells. Proc Natl Acad Sci USA 2001; 98: 690510.
  • 24
    Wakisaka N,Kondo S,Yoshizaki T,Murono S,Furukawa M,Pagano JS. Epstein-Barr virus latent membrane protein 1 induces synthesis of hypoxia-inducible factor 1 alpha. Mol Cell Biol 2004; 24: 522334.
  • 25
    Wakisaka N,Murono S,Yoshizaki T,Furukawa M,Pagano JS. Epstein-barr virus latent membrane protein 1 induces and causes release of fibroblast growth factor-2. Cancer Res 2002; 62: 633744.
  • 26
    Kondo S,Yoshizaki T,Wakisaka N,Horikawa T,Murono S,Jang KL,Joab I,Furukawa M,Pagano JS. MUC1 induced by epstein-barr virus latent membrane protein 1 causes dissociation of the cell-matrix interaction and cellular invasiveness via STAT signaling. J Virol 2007; 81: 155462.
  • 27
    Yoshizaki T,Wakisaka N,Pagano JS. Epstein-barr virus, invasion and metastasis. In: Robertson E, editor. Epstein-Barr: Pathogenesis, Molecular Biology and Infection Control. 2005.
  • 28
    Yoshizaki T,Horikawa T,Qing-chun R,Wakisaka N,Takeshita H,Sheen TS,Lee SY,Sato H,Furukawa M. Induction of interleukin-8 by Epstein-Barr virus latent membrane protein-1 and its correlation to angiogenesis in nasopharyngeal carcinoma. Clin Cancer Res 2001; 7: 194651.
  • 29
    Zheng Z,Pan J,Chu B,Wong YC,Cheung AL,Tsao SW. Downregulation and abnormal expression of E-cadherin and beta-catenin in nasopharyngeal carcinoma: close association with advanced disease stage and lymph node metastasis. Hum Pathol 1999; 30: 45866.
  • 30
    Horikawa T,Yoshizaki T,Sheen T-S,Lee S-Y,Furukawa M. Association of latent membrane protein 1 and matrix metalloproteinase 9 with metastasis in nasopharyngeal carcinoma. Cancer 2000; 89: 71523.
  • 31
    Flavell JR,Baumforth KR,Williams DM,Lukesova M,Madarova J,Noskova V,Prochazkova J,Lowe D,Kolar Z,Murray PG,Nelson P. Expression of the matrix metalloproteinase 9 in Hodgkin's disease is independent of EBV status. Mol Pathol 2000; 53: 1459.
  • 32
    Wang L,Wakisaka N,Tomlinson CC,DeWire SM,Krall S,Pagano JS,Damania B. The Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) K1 protein induces expression of angiogenic and invasion factors. Cancer Res 2004; 64: 277481.
  • 33
    Thery C,Zitvogel L,Amigorena S. Exosomes: composition, biogenesis and function. Nat Rev Immunol 2002; 2: 56979.
  • 34
    Fevrier B,Raposo G. Exosomes: endosomal-derived vesicles shipping extracellular messages. Curr Opin Cell Biol 2004; 16: 41521.
  • 35
    de Gassart A,Geminard C,Hoekstra D,Vidal M. Exosome secretion: the art of reutilizing nonrecycled proteins? Traffic 2004; 5: 896903.
  • 36
    Wolfers J,Lozier A,Raposo G,Regnault A,Thery C,Masurier C,Flament C,Pouzieux S,Faure F,Tursz T,Angevin E,Amigorena S, et al. Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming. Nat Med 2001; 7: 297303.
  • 37
    Couzin J. The ins and outs of exosomes. Science 2005; 308: 18623.
  • 38
    Hegmans JP,Bard MP,Hemmes A,Luider TM,Kleijmeer MJ,Prins JB,Zitvogel L,Burgers SA,Hoogsteden HC,Lambrecht BN. Proteomic analysis of exosomes secreted by human mesothelioma cells. Am J Pathol 2004; 164: 180715.
  • 39
    Andrei C,Dazzi C,Lotti L,Torrisi MR,Chimini G,Rubartelli A. The secretory route of the leaderless protein interleukin 1 beta involves exocytosis of endolysosome-related vesicles. Mol Biol Cell 1999; 10: 146375.
  • 40
    Thery C,Boussac M,Veron P,Ricciardi-Castagnoli P,Raposo G,Garin J,Amigorena S. Proteomic analysis of dendritic cell-derived exosomes: a secreted subcellular compartment distinct from apoptotic vesicles. J Immunol 2001; 166: 730918.
  • 41
    Thery C,Regnault A,Garin JWolfers J,Zitvogel L,Ricciardi-Castagnoli P,Raposo G,Amigorena S. Molecular characterization of dendritic cell-derived exosomes. Selective accumulation of the heat shock protein hsc73. J Cell Biol 1999; 147: 599610.
  • 42
    Dukers DF,Meij P,Vervoort MB,Vos W,Scheper RJ,Meijer CJ,Bloemena E,Middeldorp JM. Direct immunosuppressive effects of EBV-encoded latent membrane protein 1. J Immunol 2000; 165: 66370.
  • 43
    Flanagan J,Middeldorp J,Sculley T. Localization of the Epstein-Barr virus protein LMP 1 to exosomes. J Gen Virol 2003; 84: 18719.
  • 44
    Keryer-Bibens C,Pioche-Durieu C,Villemant C,Souquere S,Nishi N,Hirashima M,Middledorp J,Busson P. Exosomes released by EBV-infected nasopharyngeal carcinoma cells convey the viral latent membrane protein 1 and the immunomodulatory protein galectin 9. BMC Cancer 2006; 6: 28390.
  • 45
    Lam N,Sugden B. LMP1, a viral relative of the TNF receptor family, signals principally from intracellular compartments. EMBO J 2003; 22: 302738.
  • 46
    Rapraeger AC,Krufka A,Olwin BB. Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation. Science 1991; 252: 170508.
  • 47
    Engling A,Backhaus R,Stegmayer C,Zehe C,Seelenmeyer C,Kehlenbach A,Schwappach B,Wegehingel S,Nickel W. Biosynthetic FGF-2 is targeted to non-lipid raft microdomains following translocation to the extracellular surface of CHO cells. J Cell Sci 2002; 115: 361931.
  • 48
    Bishop N,Horman A,Woodman P. Mammalian class E vps proteins recognize ubiquitin and act in the removal of endosomal protein-ubiquitin conjugates. J Cell Biol 2002; 157: 91101.
  • 49
    Cleves AE. Protein transports: the nonclassical ins and outs. Curr Biol 1997; 7: R31820.
  • 50
    Hughes RC. Secretion of the galectin family of mammalian carbohydrate-binding proteins. Biochim Biophys Acta 1999; 1473: 17285.
  • 51
    Nickel W. The mystery of nonclassical protein secretion. A current view on cargo proteins and potential export routes. Eur J Biochem 2003; 270: 210919.
  • 52
    Nickel W. Unconventional secretory routes: direct protein export across the plasma membrane of mammalian cells. Traffic. 2005; 6: 60714.
  • 53
    Mehul B,Hughes RC. Plasma membrane targetting, vesicular budding and release of galectin 3 from the cytoplasm of mammalian cells during secretion. J Cell Sci 1997; 110: 116978.
  • 54
    Prudovsky I,Bagala C,Tarantini F,Mandinova A,Soldi R,Bellum S,Maciag T. The intracellular translocation of the components of the fibroblast growth factor 1 release complex precedes their assembly prior to export. J Cell Biol 2002; 158: 2018.
  • 55
    Mandinova A,Soldi R,Graziani I,Bagala C,Bellum S,Landriscina M,Tarantini F,Prudovsky I,Maciag T. S100A13 mediates the copper-dependent stress-induced release of IL-1alpha from both human U937 and murine NIH 3T3 cells. J Cell Sci 2003; 116: 268796.
  • 56
    Taverna S,Ghersi G,Ginestra A,Rigogliuso S,Pecorella S,Alaimo G,Saladino F,Dolo V,Dell'Era P,Pavan A,Pizzolanti G,Mignatti P, et al. Shedding of membrane vesicles mediates fibroblast growth factor-2 release from cells. J Biol Chem 2003; 278: 5191119.
  • 57
    Stoorvogel W,Kleijmeer MJ,Geuze HJ,Raposo G. The biogenesis and functions of exosomes. Traffic 2002; 3: 32130.
  • 58
    Pai S,Khanna R. Role of LMP1 in immune control of EBV infection. Semin Cancer Biol 2001; 11: 45560.